Marc Johnson, Ph.D., is the Manager of in vivo operations at Skylark Bio, where his work is focused in lab management, contracts, and CRO management.

Dr. Johnson is a member of the founding team for Skylark Bio. Dr. Johnson began his career in small molecule development at Sirtris Pharmaceuticals and has worked in a variety of modalities including T cell immunology, antibody development, and gene therapy. He earned his Ph.D. in Pharmacology and Cancer Biology from Duke University, where his research focused on T cells, metabolism, and cancer.